Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2019 Filed Jun 27, 2019 20:44 UTC |
Reedy Thomas W JREVP & CFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 77,000 | $0.00 Strike: $51.63 | $0.00 |
DisclosureSEC source: 0001170010-19-000103 · wf-form4_156166823155326.xml · derivative · entry 3 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,674 Underlying: Common Stock · 77,000 shares Expires 2023-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 12, 2017, April 12, 2018 and April 12, 2019 and become exercisable with respect to one-fourth of the underlying shares of Common Stock on April 12, 2020. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 20:44 UTC |
Reedy Thomas W JREVP & CFO
|
SaleCommon Stock | 77,000 | $83.20 | $6,406,400.00 |
DisclosureSEC source: 0001170010-19-000103 · wf-form4_156166823155326.xml · nonDerivative · entry 2 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,520 F1 · price: The shares with respect to this transaction were sold at prices ranging from $82.90 to $83.46. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 20:44 UTC |
Reedy Thomas W JREVP & CFO
|
Exercise / conversionCommon Stock | 77,000 | $51.63 | $3,975,510.00 |
DisclosureSEC source: 0001170010-19-000103 · wf-form4_156166823155326.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 20:43 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 4,800 | $0.00 Strike: $51.63 | $0.00 |
DisclosureSEC source: 0001170010-19-000102 · wf-form4_156166821377739.xml · derivative · entry 6 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,552 Underlying: Common Stock · 4,800 shares Expires 2023-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 12, 2017, April 12, 2018 and April 12, 2019 become exercisable with respect to one-fourth of the underlying shares of Common Stock on April 12, 2020. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 20:43 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
SaleCommon Stock | 4,800 | $84.09 | $403,632.00 |
DisclosureSEC source: 0001170010-19-000102 · wf-form4_156166821377739.xml · nonDerivative · entry 2 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,967 F1 · price: The shares with respect to this transaction were sold at prices ranging from $83.96 to $84.19. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 20:43 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
Exercise / conversionCommon Stock | 4,800 | $51.63 | $247,824.00 |
DisclosureSEC source: 0001170010-19-000102 · wf-form4_156166821377739.xml · nonDerivative · entry 1 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:39 UTC | GrantStock Options (Right to Buy) · Derivative | 33,967 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000080 · wf-form4_155691595722770.xml · derivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,967 Underlying: Common Stock · 33,967 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
|
| May 01, 2019 Filed May 3, 2019 20:30 UTC |
Reedy Thomas W JREVP & CFO
|
GrantStock Options (Right to Buy) · Derivative | 72,732 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000078 · wf-form4_155691540353778.xml · derivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,732 Underlying: Common Stock · 72,732 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:38 UTC |
Shamim MohammadSVP and CIO
|
GrantStock Options (Right to Buy) · Derivative | 40,542 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000079 · wf-form4_155691591442251.xml · derivative · entry 1 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,542 Underlying: Common Stock · 40,542 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:29 UTC | GrantStock Options (Right to Buy) · Derivative | 33,967 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000077 · wf-form4_155691536041879.xml · derivative · entry 1 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,967 Underlying: Common Stock · 33,967 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
|
| May 01, 2019 Filed May 3, 2019 20:28 UTC |
Nash William DPresident & CEO
|
GrantStock Options (Right to Buy) · Derivative | 237,772 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000076 · wf-form4_155691532028428.xml · derivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,772 Underlying: Common Stock · 237,772 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:28 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
GrantStock Options (Right to Buy) · Derivative | 59,145 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000075 · wf-form4_155691527736676.xml · derivative · entry 1 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,145 Underlying: Common Stock · 59,145 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:27 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantStock Options (Right to Buy) · Derivative | 49,136 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000074 · wf-form4_155691523438868.xml · derivative · entry 1 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,136 Underlying: Common Stock · 49,136 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:26 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantStock Options (Right to Buy) · Derivative | 21,828 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000073 · wf-form4_155691519638228.xml · derivative · entry 2 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,828 Underlying: Common Stock · 21,828 shares Expires 2026-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:26 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantRestricted Stock Units · Derivative | 1,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000073 · wf-form4_155691519638228.xml · derivative · entry 1 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,632 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2022. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2022. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:26 UTC |
Hill Edwin JEVP & COO
|
GrantStock Options (Right to Buy) · Derivative | 72,732 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000072 · wf-form4_155691515734810.xml · derivative · entry 1 Hill Edwin J · CIK 0001611830 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,732 Underlying: Common Stock · 72,732 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:25 UTC |
Daniels Jon GSVP, CAF
|
GrantStock Options (Right to Buy) · Derivative | 40,542 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000071 · wf-form4_155691511238427.xml · derivative · entry 1 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,542 Underlying: Common Stock · 40,542 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:24 UTC |
Cafritz Diane LSVP & CHRO
|
GrantStock Options (Right to Buy) · Derivative | 33,967 | $0.00 Strike: $78.61 | $0.00 |
DisclosureSEC source: 0001170010-19-000070 · wf-form4_155691506685232.xml · derivative · entry 1 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,967 Underlying: Common Stock · 33,967 shares Expires 2026-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2020, May 1, 2021, May 1, 2022 and May 1, 2023. Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:28 UTC |
FOLLIARD THOMAS JDirector
|
Tax withholdingCommon Stock | 2,829 | $71.10 | $201,141.90 |
DisclosureSEC source: 0001170010-19-000058 · wf-form4_155622771505566.xml · nonDerivative · entry 2 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,915 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:28 UTC |
FOLLIARD THOMAS JDirector
|
GrantCommon Stock | 6,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000058 · wf-form4_155622771505566.xml · nonDerivative · entry 1 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,744 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:28 UTC |
Shamim MohammadSVP and CIO
|
Tax withholdingCommon Stock | 641 | $71.10 | $45,575.10 |
DisclosureSEC source: 0001170010-19-000057 · wf-form4_155622767624873.xml · nonDerivative · entry 2 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,824 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:28 UTC |
Shamim MohammadSVP and CIO
|
GrantCommon Stock | 2,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000057 · wf-form4_155622767624873.xml · nonDerivative · entry 1 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,465 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:27 UTC |
Reedy Thomas W JREVP & CFO
|
Tax withholdingCommon Stock | 1,047 | $77.10 | $80,723.70 |
DisclosureSEC source: 0001170010-19-000056 · wf-form4_155622763816606.xml · nonDerivative · entry 2 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,520 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:27 UTC |
Reedy Thomas W JREVP & CFO
|
GrantCommon Stock | 3,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000056 · wf-form4_155622763816606.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,567 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:26 UTC |
Daniels Jon GSVP, CAF
|
Tax withholdingCommon Stock | 638 | $71.10 | $45,361.80 |
DisclosureSEC source: 0001170010-19-000055 · wf-form4_155622759964156.xml · nonDerivative · entry 2 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:26 UTC |
Daniels Jon GSVP, CAF
|
GrantCommon Stock | 2,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000055 · wf-form4_155622759964156.xml · nonDerivative · entry 1 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,138 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:26 UTC |
Hill Edwin JEVP & COO
|
Tax withholdingCommon Stock | 939 | $71.10 | $66,762.90 |
DisclosureSEC source: 0001170010-19-000054 · wf-form4_155622756069750.xml · nonDerivative · entry 2 Hill Edwin J · CIK 0001611830 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,570 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:26 UTC |
Hill Edwin JEVP & COO
|
GrantCommon Stock | 3,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000054 · wf-form4_155622756069750.xml · nonDerivative · entry 1 Hill Edwin J · CIK 0001611830 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,509 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:25 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
Tax withholdingCommon Stock | 642 | $71.10 | $45,646.20 |
DisclosureSEC source: 0001170010-19-000053 · wf-form4_155622751592216.xml · nonDerivative · entry 2 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,496 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:25 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantCommon Stock | 2,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000053 · wf-form4_155622751592216.xml · nonDerivative · entry 1 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,138 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:24 UTC |
Nash William DPresident & CEO
|
Tax withholdingCommon Stock | 1,618 | $71.10 | $115,039.80 |
DisclosureSEC source: 0001170010-19-000052 · wf-form4_155622747109123.xml · nonDerivative · entry 2 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,688 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:24 UTC |
Nash William DPresident & CEO
|
GrantCommon Stock | 5,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000052 · wf-form4_155622747109123.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,306 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:24 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 779 | $71.10 | $55,386.90 |
DisclosureSEC source: 0001170010-19-000051 · wf-form4_155622743141576.xml · nonDerivative · entry 2 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,967 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 21:24 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 2,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000051 · wf-form4_155622743141576.xml · nonDerivative · entry 1 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,746 Read SEC document |
| April 22, 2019 Filed Apr 25, 2019 00:08 UTC |
Nash William DPresident & CEO
|
GiftCommon Stock | 3,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000042 · wf-form4_155615089067363.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,931 Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 20:35 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $51.63 | $0.00 |
DisclosureSEC source: 0001170010-19-000038 · wf-form4_155561973675864.xml · derivative · entry 3 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,352 Underlying: Common Stock · 20,000 shares Expires 2023-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 12, 2017, April 12, 2018 and April 12, 2019 and become exercisable with respect to one-fourth of the underlying shares of Common Stock on April 12, 2020. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 20:35 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
SaleCommon Stock | 20,000 | $77.74 | $1,554,800.00 |
DisclosureSEC source: 0001170010-19-000038 · wf-form4_155561973675864.xml · nonDerivative · entry 2 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,160 F1 · price: The shares with respect to this transaction were sold at prices ranging from $77.70 to $77.83. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 20:35 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
Exercise / conversionCommon Stock | 20,000 | $51.63 | $1,032,600.00 |
DisclosureSEC source: 0001170010-19-000038 · wf-form4_155561973675864.xml · nonDerivative · entry 1 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 20:50 UTC | Exercise / conversionRestricted Stock Units · Derivative | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000034 · wf-form4_155544780563177.xml · derivative · entry 3 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,129 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 1.2423 times the number of MSUs in shares of Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on April 12, 2019 and were settled in Company common stock. F2 · derivative.expiration_date: The restricted stock units vested on April 12, 2019 and were settled in Company common stock. Read SEC document |
|
| April 12, 2019 Filed Apr 16, 2019 20:50 UTC | Tax withholdingCommon Stock | 640 | $74.45 | $47,648.00 |
DisclosureSEC source: 0001170010-19-000034 · wf-form4_155544780563177.xml · nonDerivative · entry 2 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,383 Read SEC document |
|
| April 12, 2019 Filed Apr 16, 2019 20:50 UTC | Exercise / conversionCommon Stock | 2,129 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-19-000034 · wf-form4_155544780563177.xml · nonDerivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 1.2423 times the number of MSUs in shares of Company common stock. Read SEC document |
|
| April 12, 2019 Filed Apr 16, 2019 20:49 UTC | Exercise / conversionRestricted Stock Units · Derivative | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000033 · wf-form4_155544776346908.xml · derivative · entry 3 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 1.2423 times the number of MSUs in shares of Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on April 12, 2019 and were settled in Company common stock. F2 · derivative.expiration_date: The restricted stock units vested on April 12, 2019 and were settled in Company common stock. Read SEC document |
|
| April 12, 2019 Filed Apr 16, 2019 20:49 UTC | Tax withholdingCommon Stock | 606 | $74.45 | $45,116.70 |
DisclosureSEC source: 0001170010-19-000033 · wf-form4_155544776346908.xml · nonDerivative · entry 2 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,057 Read SEC document |
|
| April 12, 2019 Filed Apr 16, 2019 20:49 UTC | Exercise / conversionCommon Stock | 2,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-19-000033 · wf-form4_155544776346908.xml · nonDerivative · entry 1 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 1.2423 times the number of MSUs in shares of Company common stock. Read SEC document |
|
| April 12, 2019 Filed Apr 16, 2019 20:49 UTC |
Cafritz Diane LSVP & CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000032 · wf-form4_155544772614204.xml · derivative · entry 3 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 1.2423 times the number of MSUs in shares of Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on April 12, 2019 and were settled in Company common stock. F2 · derivative.expiration_date: The restricted stock units vested on April 12, 2019 and were settled in Company common stock. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 20:49 UTC |
Cafritz Diane LSVP & CHRO
|
Tax withholdingCommon Stock | 690 | $74.45 | $51,370.50 |
DisclosureSEC source: 0001170010-19-000032 · wf-form4_155544772614204.xml · nonDerivative · entry 2 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,406 Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 20:49 UTC |
Cafritz Diane LSVP & CHRO
|
Exercise / conversionCommon Stock | 2,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-19-000032 · wf-form4_155544772614204.xml · nonDerivative · entry 1 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 1.2423 times the number of MSUs in shares of Company common stock. Read SEC document |
| April 09, 2019 Filed Mar 20, 2020 21:17 UTC |
FOLLIARD THOMAS JDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-20-000020 · wf-form5_158473904662943.xml · nonDerivative · entry 1 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,935 Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 20:45 UTC |
Reedy Thomas W JREVP & CFO
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-19-000028 · wf-form4_155475628823351.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,089 Read SEC document |
| April 03, 2019 Filed Apr 3, 2019 21:05 UTC |
Cafritz Diane LSVP & CHRO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,484 | $0.00 Strike: $51.63 | $0.00 |
DisclosureSEC source: 0001170010-19-000019 · wf-form4_155432553254340.xml · derivative · entry 8 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,483 Underlying: Common Stock · 3,484 shares Expires 2023-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 12, 2017 and April 12, 2018 and become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 12, 2019 and April 12, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.